Skip to main content
logo
Keymed Biosciences Inc. (HKG:2162)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
72.95
-2.30 (-3.06%)
Jul 30, 2026, 4:08 PM HKT

Keymed Biosciences Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
22,16915,7468,51613,58614,1749,651
Market Cap Growth
19.26%84.90%-37.32%-4.15%46.87%-
Enterprise Value
20,90613,6396,52610,72510,33115,170
Last Close Price
75.2553.4530.9049.1051.0034.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
27.8119.7518.6934.83125.3071.30
PB Ratio
7.185.103.234.133.762.16
P/TBV Ratio
7.205.123.254.133.762.15

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
26.2317.1114.3227.4991.33112.08

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.280.280.300.140.040.01
Net Debt / Equity Ratio
-0.41-0.41-0.57-0.77-0.91-0.96
Net Debt / EBITDA Ratio
2.072.072.555.675.8510.02
Net Debt / FCF Ratio
1.091.091.413.374.499.02
Asset Turnover
0.180.180.110.090.030.05
Inventory Turnover
0.530.530.130.660.071.02
Quick Ratio
2.492.493.048.808.4531.55
Current Ratio
2.902.903.309.368.7231.96
Return on Equity (ROE)
-19.91%-19.91%-18.85%-11.31%-8.69%-305.24%
Return on Assets (ROA)
-9.88%-9.88%-10.23%-7.32%-8.65%-10.09%
Return on Capital Employed (ROCE)
-18.70%-18.70%-20.70%-12.80%-15.30%-9.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.62%-3.69%-6.44%-2.91%-2.46%-49.44%
FCF Yield
-5.25%-7.40%-12.46%-5.53%-5.43%-4.92%
Buyback Yield / Dilution
-4.59%-4.59%-0.22%-0.09%-62.34%-139.72%